Cantor Fitzgerald Reports Key Takeaways from Call With RadioMedia CEO May 30, 2025 06:46AM
Cantor Fitzgerald reports key Takeaways from call with RadioMedia CEO May 30, 2025 06:45AM
Cantor Fitzgerald Reiterates Overweight Rating on Bicycle Therapeutics (BCYC) Jun 3, 2024 10:44AM
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update Aug 3, 2023 06:59AM
Bicycle Therapeutics Plc (BCYC) Appoints Alethia Young as Chief Financial Officer Jun 23, 2023 07:30AM


Jun 23, 2023 07:30AM Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer
Apr 7, 2022 07:14AM UPDATE: Cantor Fitzgerald Assumes Bicycle Therapeutics (BCYC) at Overweight
Jan 19, 2022 07:14AM Bicycle Therapeutics Plc (BCYC), Jazz Pharmaceuticals (JAZZ) and SAGE Therapeutics (SAGE) - Needham's Favorite 2022 Biotech Picks
Oct 1, 2020 08:10AM Bicycle Therapeutics Plc (BCYC) Announces Gross Proceeds of $50 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital
Oct 1, 2020 08:06AM Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital